Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gerdts

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Human Vaccines & Immunotherapeutics|August 22, 2017
Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virusR Garg, L Latimer, V Gerdts, et al.
Vaccine|February 1, 2015
The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodiesR Garg, L Latimer, V Gerdts, et al.
The Journal of General Virology|February 28, 2014
Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunityR Garg, L Latimer, V Gerdts, et al.
Cellular Immunology|June 29, 2002
Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifsR R Uwiera, V Gerdts, R A Pontarollo, et al.
Vaccine|November 21, 2017
Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunityR Garg, R Brownlie, L Latimer, et al.
Antiviral Research|December 15, 2018
Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambsR Garg, L Latimer, S Gomis, et al.
The Journal of General Virology|October 19, 2013
Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulationR Garg, L Latimer, E Simko, et al.
Antiviral Research|August 3, 2018
A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3R Garg, R Brownlie, L Latimer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 6, 2016
Flow cytometry as an improved method for the titration of Chlamydiaceae and other intracellular bacteriaT Käser, J A Pasternak, G Hamonic, et al.
Vaccine|December 1, 2015
Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambsR Garg, L Latimer, Y Wang, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Human Vaccines & Immunotherapeutics|August 22, 2017
Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virusR Garg, L Latimer, V Gerdts, et al.
Vaccine|February 1, 2015
The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodiesR Garg, L Latimer, V Gerdts, et al.
The Journal of General Virology|February 28, 2014
Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunityR Garg, L Latimer, V Gerdts, et al.
Cellular Immunology|June 29, 2002
Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifsR R Uwiera, V Gerdts, R A Pontarollo, et al.
Vaccine|November 21, 2017
Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunityR Garg, R Brownlie, L Latimer, et al.
Antiviral Research|December 15, 2018
Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambsR Garg, L Latimer, S Gomis, et al.
The Journal of General Virology|October 19, 2013
Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulationR Garg, L Latimer, E Simko, et al.
Antiviral Research|August 3, 2018
A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3R Garg, R Brownlie, L Latimer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 6, 2016
Flow cytometry as an improved method for the titration of Chlamydiaceae and other intracellular bacteriaT Käser, J A Pasternak, G Hamonic, et al.
Vaccine|December 1, 2015
Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambsR Garg, L Latimer, Y Wang, et al.
Pageof 3